Researcher Profile

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 111 (Search time: 0.005 seconds).

No. Year Title Type
111 2022

2022Article

TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypesCellular and Molecular Life Sciences, vol. 79, no. 1, pp. 49-49H Sun; E Kim; J Ryu; H Lee; E A Shin; M Lee; H Lee; J H Lee; J H Yoon; D G Song, et al.
Article
110 2022

2022Article

Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer modelsMolecular Therapy-Oncolytics, vol. 24, pp. 452-466Dongjoon Ko; E Kim; E A Shin; S H Nam; Junghwa Yoon; Jin-Sook Lee; Yunhee Lee; S Park; K Ha; S Y Choi, et al.
Article
109 2022

2022Article

Bioconjugated thymol-zinc oxide nanocomposite as a selective and biocompatible antibacterial agent against Staphylococcus speciesInternational Journal of Molecular Sciences, vol. 23, no. 12, pp. 6770-6770J Shin; A Naskar; Dongjoon Ko; Semi Kim; K S Kim
Article
108 2022

2022Research Project

항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
107 2022

2022Research Project

EMT-유도 전사인자에 의한 종양 면역억제미세환경 조절 기전 연구연구책임자 : 김세미 / 사업기간 : 2022.03.01 ~ 2023.02.28
Research Project
106 2021

2021Patent

암 진단 또는 치료 표적으로서 LYPD1의 용도KR10-2017-0112830 (2017.09.04) / 10-2237463 (2021.04.01)김세미; 이윤희; 김솔비
Patent
105 2021

2021Article

Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progressionJournal of Pathology, vol. 253, pp. 55-67J Ryu; E Kim; M K Kang; D G Song; E A Shin; H Lee; J W Jung; S H Nam; J E Kim; H J Kim, et al.
Article
104 2021

2021Article

A new surface charge neutralizing nano-adjuvant to potentiate polymyxins in killing Mcr-1 mediated drug-resistant Escherichia coliPharmaceutics, vol. 13, no. 2, pp. 250-250H Cho; A Naskar; S Lee; Semi Kim; K S Kim
Article
103 2021

2021Article

Bovine serum albumin-immobilized black phosphorus-based γ-Fe2O3 nanocomposites: a promising biocompatible nanoplatformBiomedicines, vol. 9, no. 8, pp. 858-858A Naskar; S Lee; Dongjoon Ko; Semi Kim; K S Kim
Article
102 2021

2021Article

TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activityJournal of Experimental & Clinical Cancer Research, vol. 40, no. 1, pp. 58-58Yunhee Lee; Dongjoon Ko; Junghwa Yoon; Y H Lee; Semi Kim
Article
101 2021

2021Article

TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1Journal of Experimental & Clinical Cancer Research, vol. 40, pp. 372-372Yunhee Lee; Junghwa Yoon; Dongjoon Ko; Minyeong Yu; S Lee; Semi Kim
Article
100 2021

2021Research Project

항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
99 2021

2021Research Project

EMT-유도 전사인자에 의한 종양 면역억제미세환경 조절 기전 연구연구책임자 : 김세미 / 사업기간 : 2021.03.01 ~ 2022.02.28
Research Project
98 2020

2020Article

A nontoxic biocompatible nanocomposite comprising black phosphorus with Au-γ-Fe2O3 nanoparticlesRsc Advances, vol. 10, pp. 16162-16167A Naskar; Semi Kim; K S Kim
Article
97 2020

2020Article

A new nano-platform of erythromycin combined with Ag nano-particle ZnO nano-structure against methicillin-resistant Staphylococcus aureusPharmaceutics, vol. 12, no. 9, pp. 841-841A Naskar; S Lee; Yunhee Lee; Semi Kim; K S Kim
Article
96 2020

2020Research Project

EMT-유도 전사인자에 의한 종양 면역억제미세환경 조절 기전 연구연구책임자 : 김세미 / 사업기간 : 2020.03.01 ~ 2021.02.28
Research Project
95 2020

2020Research Project

항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2020.01.01 ~ 2020.12.31
Research Project
94 2020

2020Research Project

간암, 대장암 치료용 First-in-Class 항체신약 후보물질 개발연구책임자 : 김세미 / 사업기간 : 2020.01.01 ~ 2021.06.30
Research Project
93 2019

2019Patent

C12orf59 유래 펩타이드를 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물KR10-2013-0111067 (2013.09.16) / 10-1965363 (2019.03.28)이윤희; 김세미
Patent
92 2019

2019Report

면역노화 조절인자 발굴 및 면역치료기술 개발 = Investigation of immune ageing regulator and immunotherapy연구책임자 : 최인표 / 주관부처 : 미래창조과학부최인표; 윤석란김태돈김세미정해용조이숙이희구조희준
Report
1 2 3 4 5 6